ANDERSON KENNETH C has a total of 13 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1929. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are NEUROTROPE BIOSCIENCE INC, LINXIS B V and YUYU PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 9 | |
#2 | WIPO (World Intellectual Property Organization) | 3 | |
#3 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Consumer goods | |
#5 | Civil engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Swimming pools | |
#4 | Peptides | |
#5 | Analysing materials | |
#6 | Laundering textiles |
# | Name | Total Patents |
---|---|---|
#1 | Anderson Kenneth C | 13 |
#2 | Hideshima Teru | 4 |
#3 | Mitsiades Nicholas | 4 |
#4 | Mitsiades Constantine S | 4 |
#5 | Chauhan Dharminder | 2 |
#6 | Mcmillin Douglas W | 2 |
#7 | Negri Joseph | 2 |
#8 | Kwiatkowski Nicholas Paul | 1 |
#9 | Mazitschek Ralph | 1 |
#10 | Shaw Jared | 1 |
Publication | Filing date | Title |
---|---|---|
CA2974270A1 | Anchor fence post assembly | |
US2010172893A1 | Use of reversine and analogs for treatment of cancer | |
US2006166947A1 | Multiple myeloma treatments | |
WO2004043374A2 | Methods and compositions for treating cancer using proteasome inhibitors | |
US1796312A | Apparatus for washing, dyeing, or otherwise treating articles with liquids |